Ultrasound enhances gene delivery of human factor IX plasmid.

Delivery of plasmid DNA can be enhanced by treatment with ultrasound (US); acoustic cavitation appears to play an important role in the process. Ultrasound contrast agents (UCAs; stabilized microbubbles) nucleate acoustic cavitation, and lower the acoustic pressure threshold for inertial cavitation occurrence. Fifty micrograms of a liver-specific, high-expressing human factor IX plasmid, pBS-HCRHP-FIXIA, mixed with UCA or phosphate-buffered saline was delivered to mouse livers by intrahepatic injection, with simultaneous exposure to 1 MHz-pulsed US using various acoustic protocols. Variable pulse duration (PD) at constant treatment time, pulse repetition frequency, and an acoustic peak negative pressure amplitude of 1.8 MPa produced 2- to 13-fold enhancements in hFIX gene expression, but PD was not a strong determinant. In contrast, a dose-response relationship was demonstrated for the peak negative pressure (P-), with significant enhancement of gene transduction at P- >/= 2 MPa. Up to 63 ng/ml (approaching the therapeutic range for treating hemophilia patients) could be achieved by transducing one liver lobe at 4-MPa P-, corresponding to a 66- fold increment relative to treatment with naked DNA alone. Under the same conditions, mouse livers could also be transduced with a GFP plasmid. Histology showed transient liver damage caused by intrahepatic injection and US exposure at 4-MPa P-; however, the damage was repaired in a few days. We conclude that therapeutic US in combination with UCA has the potential to promote safe and efficient nonviral gene transfer of hFIX for the treatment of hemophilia.

[1]  Y. Taniyama,et al.  Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound , 2004, Gene Therapy.

[2]  K. High.  Clinical gene transfer studies for hemophilia B. , 2004, Seminars in thrombosis and hemostasis.

[3]  K. Tachibana,et al.  Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results. , 2003, Radiology.

[4]  Theresa A. Storm,et al.  Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. , 2003, Blood.

[5]  C. Miao,et al.  High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors. , 2003, Human gene therapy.

[6]  Peng Li,et al.  Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, pressure amplitude and contrast dose. , 2003, Ultrasound in medicine & biology.

[7]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[8]  A. Brayman,et al.  A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents. , 2003, The Journal of the Acoustical Society of America.

[9]  K. Loeb,et al.  Complete and sustained phenotypic correction of hemophilia B in mice following hepatic gene transfer of a high‐expressing human factor IX plasmid , 2003, Journal of thrombosis and haemostasis : JTH.

[10]  Douglas L. Miller,et al.  Sonoporation: Mechanical DNA Delivery by Ultrasonic Cavitation , 2002, Somatic cell and molecular genetics.

[11]  E. Unger,et al.  Therapeutic applications of microbubbles. , 2002, European journal of radiology.

[12]  Y. Kaneda,et al.  Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Y. Taniyama,et al.  Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound , 2002, Circulation.

[14]  Y. Taniyama,et al.  Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle , 2002, Gene Therapy.

[15]  Yang Liu,et al.  Therapeutic ultrasound: Its application in drug delivery , 2002, Medicinal research reviews.

[16]  K. Hynynen,et al.  Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. , 2001, Radiology.

[17]  E. Unger,et al.  Local drug and gene delivery through microbubbles. , 2001, Progress in cardiovascular diseases.

[18]  K. Loeb,et al.  Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  E. Unger,et al.  Gene Delivery Using Ultrasound Contrast Agents , 2001, Echocardiography.

[20]  D. Cumberland,et al.  Ultrasound Gene Therapy: On the Road from Concept to Reality , 2001, Echocardiography.

[21]  E. Carstensen,et al.  Bioeffects of positive and negative acoustic pressures in mice infused with microbubbles. , 2000, Ultrasound in medicine & biology.

[22]  M. Nakamura,et al.  Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. , 2000, Human gene therapy.

[23]  R V Shohet,et al.  Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. , 2000, Circulation.

[24]  J D Thomas,et al.  Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. , 2000, Journal of the American College of Cardiology.

[25]  D. Miller,et al.  The influence of ultrasound frequency and gas-body composition on the contrast agent-mediated enhancement of vascular bioeffects in mouse intestine. , 2000, Ultrasound in medicine & biology.

[26]  S. Snyder,et al.  Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization , 1999, Nature Medicine.

[27]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[28]  J. Wolff,et al.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. , 1999, Human gene therapy.

[29]  D. Miller,et al.  Gas-body-based contrast agent enhances vascular bioeffects of 1.09 MHz ultrasound on mouse intestine. , 1998, Ultrasound in medicine & biology.

[30]  T C Skalak,et al.  Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and Its Local Effects on Tissue. , 1998, Circulation.

[31]  F A Jolesz,et al.  Non-invasive opening of BBB by focused ultrasound. , 2003, Acta neurochirurgica. Supplement.

[32]  M. Kay,et al.  Efficient lentiviral transduction of liver requires cell cycling in vivo , 2000, Nature Genetics.

[33]  Katherine A. High,et al.  Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector , 1999, Nature Medicine.

[34]  Ronald A. Roy,et al.  Liver hemostasis using high-intensity focused ultrasound. , 1997, Ultrasound in medicine & biology.

[35]  D. Miller,et al.  Ultrasonically induced hemolysis at high cell and gas body concentrations in a thin-disc exposure chamber. , 1997, Ultrasound in medicine & biology.